Status | Study |
Terminated |
Study Name: Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3 Condition: Long QT Syndrome Type 3 Date: 2014-11-21 Interventions: Drug: Eleclazine Eleclazine ta |
Completed |
Study Name: Study of the Effect of GS-6615 in Subjects With LQT-3 Condition: Long QT Syndrome Date: 2013-05-06 Interventions: Drug: GS-6615 GS-6615 tablet(s) administered orally |
Recruiting |
Study Name: Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine Condition: Long QT Syndrome Type 3 Date: 2012-11-12 Interventions: Drug: Ranolazine Other Name: Ranexa |
Recruiting |
Study Name: Efficacy Study of Sodium Channel Blocker in LQT3 Patients Condition: Long QT Syndrome Date: 2012-07-18 Interventions: Drug: Placebo Matching Placebo |
Recruiting |
Study Name: Worm Study: Modifier Genes in Sudden Cardiac Death Condition: Date: 2024-03-29 |